Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX
To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer.
Gespeichert in:
| Autor*in: |
Lledo, Gérard [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study - Hamzah, N. ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:56 ; year:2016 ; pages:115-121 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejca.2015.12.020 |
|---|
| Katalog-ID: |
ELV019627335 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019627335 | ||
| 003 | DE-627 | ||
| 005 | 20230623151753.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2015.12.020 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000101A.pica |
| 035 | |a (DE-627)ELV019627335 | ||
| 035 | |a (ELSEVIER)S0959-8049(15)01176-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Lledo, Gérard |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| 264 | 1 | |c 2016 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. | ||
| 650 | 7 | |a Oesophageal cancer |2 Elsevier | |
| 650 | 7 | |a Oxaliplatin |2 Elsevier | |
| 650 | 7 | |a Radiotherapy |2 Elsevier | |
| 650 | 7 | |a FOLFOX |2 Elsevier | |
| 650 | 7 | |a Cetuximab |2 Elsevier | |
| 650 | 7 | |a Chemoradiotherapy |2 Elsevier | |
| 700 | 1 | |a Huguet, Florence |4 oth | |
| 700 | 1 | |a Chibaudel, Benoist |4 oth | |
| 700 | 1 | |a Di Fiore, Frédéric |4 oth | |
| 700 | 1 | |a Mineur, Laurent |4 oth | |
| 700 | 1 | |a Galais, Marie-Pierre |4 oth | |
| 700 | 1 | |a Artru, Pascal |4 oth | |
| 700 | 1 | |a Blondin, Valérie |4 oth | |
| 700 | 1 | |a Dupuis, Olivier |4 oth | |
| 700 | 1 | |a Abdiche, Menouar Samir |4 oth | |
| 700 | 1 | |a Jovenin, Nicolas |4 oth | |
| 700 | 1 | |a Pozet, Astrid |4 oth | |
| 700 | 1 | |a Bonnetain, Franck |4 oth | |
| 700 | 1 | |a Attia, Mohamed |4 oth | |
| 700 | 1 | |a Dahan, Laetitia |4 oth | |
| 700 | 1 | |a de Gramont, Aimery |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hamzah, N. ELSEVIER |t The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV000241849 |
| 773 | 1 | 8 | |g volume:56 |g year:2016 |g pages:115-121 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2015.12.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 56 |j 2016 |h 115-121 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
g l gl |
|---|---|
| matchkey_str |
lledogrardhuguetflorencechibaudelbenoist:2016----:hmrdohrpwtflopuctxmbnoalavneospaelacr |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.52 |
| publishDate |
2016 |
| allfields |
10.1016/j.ejca.2015.12.020 doi GBV00000000000101A.pica (DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Lledo, Gérard verfasserin aut Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier Huguet, Florence oth Chibaudel, Benoist oth Di Fiore, Frédéric oth Mineur, Laurent oth Galais, Marie-Pierre oth Artru, Pascal oth Blondin, Valérie oth Dupuis, Olivier oth Abdiche, Menouar Samir oth Jovenin, Nicolas oth Pozet, Astrid oth Bonnetain, Franck oth Attia, Mohamed oth Dahan, Laetitia oth de Gramont, Aimery oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:56 year:2016 pages:115-121 extent:7 https://doi.org/10.1016/j.ejca.2015.12.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 56 2016 115-121 7 045F 610 |
| spelling |
10.1016/j.ejca.2015.12.020 doi GBV00000000000101A.pica (DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Lledo, Gérard verfasserin aut Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier Huguet, Florence oth Chibaudel, Benoist oth Di Fiore, Frédéric oth Mineur, Laurent oth Galais, Marie-Pierre oth Artru, Pascal oth Blondin, Valérie oth Dupuis, Olivier oth Abdiche, Menouar Samir oth Jovenin, Nicolas oth Pozet, Astrid oth Bonnetain, Franck oth Attia, Mohamed oth Dahan, Laetitia oth de Gramont, Aimery oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:56 year:2016 pages:115-121 extent:7 https://doi.org/10.1016/j.ejca.2015.12.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 56 2016 115-121 7 045F 610 |
| allfields_unstemmed |
10.1016/j.ejca.2015.12.020 doi GBV00000000000101A.pica (DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Lledo, Gérard verfasserin aut Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier Huguet, Florence oth Chibaudel, Benoist oth Di Fiore, Frédéric oth Mineur, Laurent oth Galais, Marie-Pierre oth Artru, Pascal oth Blondin, Valérie oth Dupuis, Olivier oth Abdiche, Menouar Samir oth Jovenin, Nicolas oth Pozet, Astrid oth Bonnetain, Franck oth Attia, Mohamed oth Dahan, Laetitia oth de Gramont, Aimery oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:56 year:2016 pages:115-121 extent:7 https://doi.org/10.1016/j.ejca.2015.12.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 56 2016 115-121 7 045F 610 |
| allfieldsGer |
10.1016/j.ejca.2015.12.020 doi GBV00000000000101A.pica (DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Lledo, Gérard verfasserin aut Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier Huguet, Florence oth Chibaudel, Benoist oth Di Fiore, Frédéric oth Mineur, Laurent oth Galais, Marie-Pierre oth Artru, Pascal oth Blondin, Valérie oth Dupuis, Olivier oth Abdiche, Menouar Samir oth Jovenin, Nicolas oth Pozet, Astrid oth Bonnetain, Franck oth Attia, Mohamed oth Dahan, Laetitia oth de Gramont, Aimery oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:56 year:2016 pages:115-121 extent:7 https://doi.org/10.1016/j.ejca.2015.12.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 56 2016 115-121 7 045F 610 |
| allfieldsSound |
10.1016/j.ejca.2015.12.020 doi GBV00000000000101A.pica (DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Lledo, Gérard verfasserin aut Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier Huguet, Florence oth Chibaudel, Benoist oth Di Fiore, Frédéric oth Mineur, Laurent oth Galais, Marie-Pierre oth Artru, Pascal oth Blondin, Valérie oth Dupuis, Olivier oth Abdiche, Menouar Samir oth Jovenin, Nicolas oth Pozet, Astrid oth Bonnetain, Franck oth Attia, Mohamed oth Dahan, Laetitia oth de Gramont, Aimery oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:56 year:2016 pages:115-121 extent:7 https://doi.org/10.1016/j.ejca.2015.12.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 56 2016 115-121 7 045F 610 |
| language |
English |
| source |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:56 year:2016 pages:115-121 extent:7 |
| sourceStr |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:56 year:2016 pages:115-121 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
Oesophageal cancer Oxaliplatin Radiotherapy FOLFOX Cetuximab Chemoradiotherapy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| authorswithroles_txt_mv |
Lledo, Gérard @@aut@@ Huguet, Florence @@oth@@ Chibaudel, Benoist @@oth@@ Di Fiore, Frédéric @@oth@@ Mineur, Laurent @@oth@@ Galais, Marie-Pierre @@oth@@ Artru, Pascal @@oth@@ Blondin, Valérie @@oth@@ Dupuis, Olivier @@oth@@ Abdiche, Menouar Samir @@oth@@ Jovenin, Nicolas @@oth@@ Pozet, Astrid @@oth@@ Bonnetain, Franck @@oth@@ Attia, Mohamed @@oth@@ Dahan, Laetitia @@oth@@ de Gramont, Aimery @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000241849 |
| dewey-sort |
3610 |
| id |
ELV019627335 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019627335</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623151753.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2015.12.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000101A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019627335</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(15)01176-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lledo, Gérard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oesophageal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oxaliplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FOLFOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cetuximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoradiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huguet, Florence</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chibaudel, Benoist</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Di Fiore, Frédéric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mineur, Laurent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galais, Marie-Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Artru, Pascal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blondin, Valérie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dupuis, Olivier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdiche, Menouar Samir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jovenin, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pozet, Astrid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonnetain, Franck</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Attia, Mohamed</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dahan, Laetitia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Gramont, Aimery</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:115-121</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2015.12.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2016</subfield><subfield code="h">115-121</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Lledo, Gérard |
| spellingShingle |
Lledo, Gérard ddc 610 bkl 44.52 Elsevier Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| authorStr |
Lledo, Gérard |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000241849 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.52 bkl Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy |
| topic_browse |
ddc 610 bkl 44.52 Elsevier Oesophageal cancer Elsevier Oxaliplatin Elsevier Radiotherapy Elsevier FOLFOX Elsevier Cetuximab Elsevier Chemoradiotherapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f h fh b c bc f f d ff ffd l m lm m p g mpg p a pa v b vb o d od m s a ms msa n j nj a p ap f b fb m a ma l d ld g a d ga gad |
| hierarchy_parent_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| hierarchy_parent_id |
ELV000241849 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000241849 |
| title |
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| ctrlnum |
(DE-627)ELV019627335 (ELSEVIER)S0959-8049(15)01176-4 |
| title_full |
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| author_sort |
Lledo, Gérard |
| journal |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| journalStr |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
115 |
| author_browse |
Lledo, Gérard |
| container_volume |
56 |
| physical |
7 |
| class |
610 610 DE-600 610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lledo, Gérard |
| doi_str_mv |
10.1016/j.ejca.2015.12.020 |
| dewey-full |
610 |
| title_sort |
chemoradiotherapy with folfox plus cetuximab in locally advanced oesophageal cancer: the gercor phase ii trial erafox |
| title_auth |
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| abstract |
To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. |
| abstractGer |
To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. |
| abstract_unstemmed |
To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX |
| url |
https://doi.org/10.1016/j.ejca.2015.12.020 |
| remote_bool |
true |
| author2 |
Huguet, Florence Chibaudel, Benoist Di Fiore, Frédéric Mineur, Laurent Galais, Marie-Pierre Artru, Pascal Blondin, Valérie Dupuis, Olivier Abdiche, Menouar Samir Jovenin, Nicolas Pozet, Astrid Bonnetain, Franck Attia, Mohamed Dahan, Laetitia de Gramont, Aimery |
| author2Str |
Huguet, Florence Chibaudel, Benoist Di Fiore, Frédéric Mineur, Laurent Galais, Marie-Pierre Artru, Pascal Blondin, Valérie Dupuis, Olivier Abdiche, Menouar Samir Jovenin, Nicolas Pozet, Astrid Bonnetain, Franck Attia, Mohamed Dahan, Laetitia de Gramont, Aimery |
| ppnlink |
ELV000241849 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ejca.2015.12.020 |
| up_date |
2024-07-06T21:56:49.971Z |
| _version_ |
1803868448984399872 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019627335</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623151753.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2015.12.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000101A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019627335</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(15)01176-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lledo, Gérard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oesophageal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oxaliplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FOLFOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cetuximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoradiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huguet, Florence</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chibaudel, Benoist</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Di Fiore, Frédéric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mineur, Laurent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galais, Marie-Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Artru, Pascal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blondin, Valérie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dupuis, Olivier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdiche, Menouar Samir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jovenin, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pozet, Astrid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonnetain, Franck</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Attia, Mohamed</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dahan, Laetitia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Gramont, Aimery</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:115-121</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2015.12.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2016</subfield><subfield code="h">115-121</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398429 |